Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Trial Profile

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2018

At a glance

  • Drugs Nalmefene (Primary) ; Nalmefene (Primary)
  • Indications Alcoholism; Opioid abuse
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Feb 2018 Results published in an Aegis Therapeutics Media Release
    • 22 Feb 2018 This trial was conducted by the National Institute on Drug Abuse (NIDA) under a clinical trial agreement with Opiant Pharmaceuticals Inc, as reported in an Aegis Therapeutics media release.
    • 10 Jul 2017 Status changed from not yet recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top